The Veterinary Laboratories Agency has worked in collaboration with the Institute of Animal Health (IAH) at Pirbright to introduce the Polymerase Chain Reaction (PCR) test for Bluetongue virus.
This test is now available via veterinary surgeons for pre-movement (UK) and export testing purposes only.
As of this date, PCR testing for these purposes will no longer be available from IAH, Pirbright.
For further information see www.vla.gov.uk
.
Cats Protection and Dogs Trust have launched an awards scheme inviting veterinary students to submit a series of three feline or canine case studies.
The Clinical Cases Study Awards 2010 encourage students to highlight the differential diagnoses and treatment regimes in a 1,500 word report.
The selected cases should be related, and animals can be from the UK or overseas. Reports should include a brief introduction, common presenting signs, possible causes of the animal's condition or illness and a diagnosis, prognosis and treatment plan for each animal, with photographs included as appropriate.
There will be separate prizes for the best feline report and the best canine report. Each winner will receive £500 and the chance to have their report summary published in a Cats Protection or Dogs Trust magazine, whilst runners-up in each category will receive £250.
Guidance notes to help students draft their report are available from either charity. Reports should be sent with a covering letter and a CV to veterinary@cats.org.uk to arrive no later than 1 March 2010.
Shortlisted candidates will be invited to a judging day on 6 April at Dogs Trust's Rehoming Centre in Kenilworth. Selected finalists will have the opportunity to attend the BSAVA Congress in Birmingham, where the winners will be announced at an awards ceremony on 9 April.
Maggie Roberts, Cats Protection's Director of Veterinary Services said: "As a charity that helps over 193,000 unwanted cats each year, Cats Protection works closely with the veterinary profession and recognises how important today's veterinary students are to the future of feline welfare. Cats are intriguing creatures and their diseases can be complex. It will be interesting to see the range of cases the students present."
Chris Laurence, Veterinary Director at Dogs Trust added: "This is the first time we have invited veterinary students to submit case studies for the awards and I hope that universities will support the scheme by encouraging their students to enter. We see the awards as an introduction point for students to engage with two of the leading welfare charities - something that will be a beneficial experience and potentially assist them with their future careers."
Further information can be obtained from either Gemma Lovegrove at Cats Protection on 01825 741991 or email veterinary@cats.org.uk or from Chris Laurence at Dogs Trust on 02078 337 662 or email chris.laurence@dogstrust.org.uk
Bayer Animal Health, manufacturer of Advocate, is launching an advertising campaign to support its 'Be Lungworm Aware' initiative, which aims to educate pet owners on the spread of Angiostrongylus vasorum and encourage them to seek advice from their local veterinary practice.
The campaign will see a new TV 'public information' style advertisement targeting dog owners. It will air on 20 national TV channels during April including ITV1, 2 and 3, Sky 1, 2 and 3, More 4 and Film4, with air time dedicated to GMTV and daytime ITV.
The TV advertising campaign will focus on the parasite's intermediate hosts - slugs and snails - and the ease in which dogs can become infected with the parasite by picking up something as simple as a toy with a slug attached to it.
Print advertisements will also be running in national newspapers and women's consumer magazines with a focus on publications read by pet owners.
Marketing support material is available for veterinary practices wishing to participate in the 'Be Lungworm Aware' initiative. For further details, or to order the new practice materials, please contact your Bayer representative or ring 0845 2574798 quoting 'Be Lungworm Aware'.
The Feline Advisory Bureau (FAB) has changed its name to International Cat Care in order to better reflect the work the charity does to help improve the lives of cats both in the UK and internationally.
Along with the name change, the charity has developed a completely new visual identity, which has been applied to its new website (www.icatcare.org).
Claire Bessant, CEO of International Cat Care, said: "We continue to evolve as a charity and we are increasingly working internationally to help vets and local communities provide better care for cats. While our mission and core values will remain the same, we needed a strong brand identity to better reflect this work and to help us engage more directly with consumers and vets."
Underneath the International Cat Care umbrella, there are three core areas which are designed to help streamline the charity's work and make it easy for vets, professionals and consumers to engage in the right way. The three areas are:
The charity's new website will continue to host information and advice on virtually every aspect of cat care, but also showcases the charity's work internationally. Most recently, the team has been in Sudan teaching vets about the safe handling and neutering of cats, with a special emphasis on street cats.
Claire Bessant continued: "We really wanted to achieve a clear and succinct explanation of who we are and what we do, and we think the new name and visual identity perfectly sums this up. It's been such a rewarding process because the rebrand has been so positively received by our dedicated staff, members and supporters."
International Cat Care will be officially unveiled on the first day of this year's BSAVA Congress, where vets and the media will be invited to the stand to see the new identity for the first time, and for a glass of celebratory champagne.
To meet the team and find out more about the rebrand, visit stand 704 at the BSAVA Congress.
The RCVS has launched its new Fellowship scheme and is now accepting applications from veterinary surgeons who have made a meritorious contribution to their particular field.
The new Fellowship scheme was launched with three routes to membership: meritorious contributions to knowledge; meritorious contributions to clinical practice; and meritorious contributions to the profession.
The changes were approved by RCVS Council at its June 2015 meeting, following a public consultation on how the Fellowship could be developed to move it away from being an examination-based award, to becoming a learned society.
Dr Bradley Viner, President of the RCVS, said: "I am very proud to announce the launch of the new Fellowship scheme and I hope that, as a learned body, the Fellowship will help advance and develop clinical and professional standards by sharing their knowledge and expertise with the profession.
"The move from being an examinations-based award to the three new paths to entry is a significant development as it will widen the reach of the Fellowship, particularly to those who are working in clinical practice.
"I would strongly encourage all those who feel they have made a meritorious contribution to any of these three areas to apply as I am very hopeful we will be able to award our first group of new Fellowships at RCVS Day on Friday 15 July."
The criteria for achieving Fellowship includes sustained contribution to scholarship; producing a body of creative work that has been disseminated to others; indisputable advancement of their subject; providing leadership to the profession; and, advancement of the public understanding of the profession.
Each application will be assessed by a Credentials Panel to see if it meets the proposed criteria. Applications approved by the Panel will then be put to the Fellowship Board, which will meet once a year to consider the overall list of proposed applications.
The closing date for initial applications is Wednesday 11 May. Application forms for the three different routes to Fellowship, as well as further details about criteria and a list of relevant doctorate programmes, can be found at www.rcvs.org.uk/fellowship
All current Fellows, including Honorary Fellows, will retain their FRCVS/HonFRCVS status.
The day will be led by Sonya Miles, BVSc CertAVP (ZM), CertAqV, MRCVS, RCVS Recognised Advanced Practitioner in Zoological Medicine and WAVMA Certified Aquatic Species Veterinarian.
Lectures will look at techniques, protocols, potential drug options and combinations as well as blood sampling and hospitalisation techniques in a wide variety of exotic species.
Delegates will also be provided with lecture notes, a CPD certificate, refreshments and lunch, as well as goodie bags provided by sponsors Pinmoore Animal Laboratory Services Limited.
Sonya says the aim of the day is to dispel many myths associated with anaesthetising a wide variety of exotic species, including fish and amphibians, whilst simultaneously providing vets and nurses with the skills to undertake these often challenging and comparatively high-risk anaesthetics.
To book your place or for more information, email: info@justexotics.co.uk or book online at https://justexoticsevents.co.uk/dont-miss-out-on-our-latest-event
Alfaxan®, Vetoquinol's injectable general anaesthetic, is one year old this month. To celebrate the occasion, and the product's use by 860 UK practices in over 80,000 procedures so far, Vetoquinol is offering a free Alfaxan party bag.
The party bag includes an Alfaxan anaesthesia monitoring chart and an Alfaxan vet brochure with dosage chart and timer. In addition, everyone who claims a party bag will be entered into a lucky dip. Ten winners will be chosen at random to receive an oesophageal stethoscope kit, containing one normal stethoscope, with a removable head, and three Portex oesophageal stethoscope probes (small, medium and large) for monitoring patient’s heart and respiratory rate.
To claim your party bag, call the dedicated Alfaxan technical support line on 0800 345 7560 or email: MyAlfaxanPartyBag@vetoquinol.co.uk.
Vetoquinol also reports a very positive response to Alfaxan from the profession during its first year. Simon Boulton, one of Vetoquinol’s Veterinary Advisors, has been conducting wet labs across the country for the company. He said: "Vets have used the wet lab service to get me along to anaesthetize patients for the day using Alfaxan. I have had a great deal of positive feedback and the product is becoming more and more widely used. Extremely smooth and reliable inductions, followed by good cardiovascular and respiratory stability were the most noticeable features of Alfaxan anaesthesia, liked by both the vets anaesthetizing the patients and the nurses who monitor them."
Novartis Animal Health UK has announced that it is committed to maintaining a reliable supply of Bovidec BVD virus vaccine throughout the coming season.
The announcement comes following concerns surrounding the availability of BVD vaccines. Novartis Brand Manager Eugene Smyth said: "We have been in discussion with the regulatory authorities to try and ensure we can meet the demand over the coming months and we have a large team of territory managers and technical services veterinarians dedicated to supporting our customers through the season".
Bovidec BVD virus vaccine, immunises adult cattle against the BVD Type 1 virus and for active immunisation of calves against BVD Type II virus.
Purina is inviting practices to participate in its inaugural UK Feline Dental Health Month, which starts on 1st July 2014.
As part of the initiative, participating practices are being asked to give their cat-owning clients free dental health checks throughout July to help improve the health of feline patients, build client loyalty and boost revenue.
Purina says Feline Dental Health Month has been created to help practices educate cat-owning clients about the importance of dental health. As many cat owners are unable or unwilling to check their cat's mouth and teeth due to the discreet nature of their pet, they rely on their vet to highlight potential problems. Feline dental disease is estimated to affect around three quarters of cats over the age of three, making it the most prevalent health condition seen amongst pet cats. Often painful and with the capability to cause systemic problems, dental problems in cats can represent a serious welfare problem if left untreated.
To help practices promote Feline Dental Health Month to their clients, Purina has prepared a support pack which includes waiting room promotional materials and client care leaflets with money off coupons. Practices will also be given a step-by-step publicity plan so they can promote the month in their local media and via their existing communications channels.
Purina says that signing up to the Feline Dental Health Month will mean that practices benefit from more contact with a client group that is potentially less engaged with their pet's health and also attract new clients via the promotional activity. This will provide an increase in opportunities to discuss other common health concerns with their clients and offer the potential to boost sales of products and services.
Chris Nickson, Senior Brand Manager, Purina Vet Channel said: "Feline Dental Health Month promotes the idea that prevention is better than cure. To avoid more serious procedures that can put stress on the owner and cat, Purina advocates ongoing management of dental hygiene. Our veterinary support packs provide everything a practice will need to have a very successful Feline Health Month."
Purina has also developed Pro Plan Cat Dental Plus, a diet designed to maintain healthy teeth and gums in cats. As part of Feline Dental Health Month, Purina is offering owners £5 off their first bag.*
To sign up for Feline Dental Health Month, speak to your Purina representative or call the Pro Plan Vet helpline on 0800 032 6418.
The course will cover reptiles, pet mammals and captive birds.
Marie says the course will teach you how to approach exotic emergencies confidently, from clinical examination and forming differential diagnoses to medical and surgical approaches for common emergency presentations.
Marie will discuss both clinical management and the stabilisation and care of the critical patient, including fluid therapy, analgesia, contra-indicated medications and hospital cage requirements.
Welfare-focused euthanasia approaches will also be covered for different species.
Tickets cost £300 and the course is open to veterinary surgeons, veterinary nurses and students on a recognised veterinary or nursing course.
Lunch, tea, coffee and biscuits included.
https://evolutionexoticsreferrals.co.uk/cpd-booking-form/
The Walpole Bay Tidal Pool is the biggest in the UK, covering four acres.
Everyone taking part is being challenged to raise at least £100 for Vetlife, to go towards its helpline, health support and financial support for the veterinary community.
Sea temperature at this time of year is a decidedly brisk 10 degrees Celsius, but Vetlife says the dress code is reasonably relaxed: anything from a swimming costume to a full diving dry suit!
https://events.more-human.co.uk/event/1713190086537x259173669533122560
Pfizer, manufacturer of the wormer Strongid™-P has launched a new promotional campaign. Love your horse is based on simple, straightforward and unbiased educational messages to help ensure the optimum health and wellbeing of horses and ponies in the UK.
Pfizer's veterinary adviser Ben Gaskell said: “Simplistically, the three key tools for the horse owner to understand are diagnostics, worming and pasture management. If these tools are used in combination with specialist advice, then the horse owner will be able to provide a sustainable, reliable and cost-effective worm control strategy for their horse.”
At the core of the campaign is a new range of four highly informative and uncomplicated leaflets directed at every type of horse owner: Do you need to worm; Choosing and using the right wormer; Managing your pasture and Worming and Your new horse.
“Each leaflet has been designed to work as a stand-alone piece or can be presented as a smart, matching series of four,” said Helen Shirley, brand manager for Strongid™-P. “The leaflets can be displayed in-store in a distinctive counter-top leaflet dispenser and are supported by eye-catching point of sale materials including posters and balloons." The new campaign packs will be rolled out to all stockists from early June, supported by a dramatic new Love your horse advertisement in national equestrian trade and consumer titles.
The campaign will build up momentum over the summer months and into autumn’s double dosing time with a series of authoritative, no-nonsense features and news stories from Strongid™-P’s veterinary advisor Ben Gaskell.
For further information please email: Strongid-P@pfizer.com
Novartis Animal Health has launched its Summer Worming Packs.
The packs are part of an ongoing campaign by the company to get pet owners to worm their animals at least 4 times a year (as recommended by the European Scientific Counsel Companion Animal Parasites1), as opposed to the current norm of 2.6 times per year2.
The Summer Worming Packs include waiting room and client materials, and practice PR support materials. There is also a pet owner website http://www.wormpatrol.co.uk/.
For further details about the Summer Worming Pack or the Worm Patrol Campaign, veterinary practices should contact their Novartis Animal Health Territory Manager.
Virbac has announced the launch of My Virbac, a new website offering a range of business, marketing and technical services for veterinary professionals.
The main elements of My Virbac are:
Virbac Product Manager, Ms Victoria Hudson said: "Virbac was one of the pioneers of the concept of practice support and the services we already offer are highly valued by our customers. In developing My Virbac, we're taking things to a new level. We've worked with business and veterinary experts to develop a practical and helpful range of services which will make a real difference to practices that use them. We plan to add additional services and tools on a regular basis.
"As the veterinary sector becomes increasingly competitive, providing an outstanding clinical service is no longer enough. Practices must also be well-run businesses, with a strong focus on marketing and client retention. Taking advantage of the services and tools available on My Virbac will help practices to ensure they are well placed to succeed even in difficult times."
To access Virbac's services platform, practices and individuals can register at www.my-virbac.co.uk.
The panel, chaired by veterinary ethicist Professor David Morton CBE, was established last year on a trial basis as a means of offering an ethical review process for practice-based research projects that may not have the same access to resources as clinical studies in academia or industry.
Since its establishment at the end of July last year it has received 23 applications, mostly concerning small animal clinical studies. However, due to demand from the profession, it will shortly be considering applications for equine or farm animal-based research and will be recruiting new panel members to cover these areas.
Eleanor Ferguson, RCVS Registrar, said: "Although the number of cases considered so far have been relatively small, the service has been very well received as a means of providing ethical review to those who might not otherwise be able to do so and so, therefore, might struggle to get papers published.
"Considering the importance of practice-based research we expect there to be an increase in the number of applications as word gets out about the service and so are happy to extend the trial for another year and for it to consider a wider range of applications."
Further details about the Panel, as well as guidelines for making applications and the application forms, can be found at www.rcvs.org.uk/ethics
For an initial discussion about submitting an application to the Ethics Review Panel, contact Beth Jinks, Standards and Advisory Officer, on 020 7202 0764 or ethics@rcvs.org.uk
The company has set up the Group Veterinary Medical Board (GVMB) Research Fund to offer practical support and financial assistance.
Deputy Chief Medical Officer Alistair Cliff (pictured right), said: "We introduced funding for research across our European Group at the beginning of this year and have been overwhelmed by the interest this has received. We understand the importance of these opportunities for professional development and also an individual’s job satisfaction.
“We believe it is incumbent upon us to increase this support for research to contribute to the advancement of knowledge, the development of our teams and our value as an employer. Ensuring our teams are content, with a diverse range of ways to develop, is important in allowing us to continue to attract the best people in the profession.
The GVMB Research Fund made its first awards in June 2021. Seven grants were provided to research teams from three countries – the UK, The Netherlands and France. In total, the funding will benefit some 21 researchers working as interns, residents, referral clinicians and specialists from a variety of different settings.
Chief Medical Officer Amanda Boag said: "It is incredibly satisfying to be able to provide support to our teams at critical points of their professional development. In some cases, funding has been provided to experienced researchers looking to contribute yet more to the understanding within their respective disciplines. In other examples, we have supported interns, who are at the very beginning of that journey and at a stage where funding can be difficult to secure.”
She added: “With additional interest from several general practitioners and nurses, the fund has quickly become a significant benefit to working for IVC Evidensia."
The GVMB also provides resources to guide teams on study design, ethical requirements, and statistical support. Less experienced researchers can access a network of Research Partners - a group of experienced clinicians from around Europe who have volunteered their own time to mentor colleagues through a collaborative approach to a project.
Scandinavian Micro Biodevices (SMB) has launched its new diagnostic device: QuickVet Analyzer. The device brings novel ‘point of care’ testing to the clinic.
The QuickVet Analyzer and QuickVet COAG test cartridge provide analytical results in pets’ blood samples to help diagnose a range of conditions such as:
Investigating potential coagulation problems is an important pre-operative procedure.
SMB Chief Executive Officer, Mr Ole Kring, said: “The QuickVet Analyzer is simple to use, requires no routine maintenance and delivers results of high precision.”
The SMB device brings state of the art, ‘lab-on-a-chip’ concept from human diagnostics to the veterinary clinic, giving vets diagnostic test results in approximately ten minutes. Instead of waiting until the next day for the result, vets can offer pet owners an instant diagnosis.
The Quickvet Analyzer uses individual test cartridges based on microfluidic technology. The first test cartridge to be launched - the QuickVet COAG test - will analyse the intrinsic activated partial thromboplastin time (aPTT) and extrinsic partial thromboplastin time (PT) coagulation cascade from citrated whole blood in just minutes at an unmatched precision level of 7% CV in the relevant diagnostic range.
With touch screen operation, the instrument requires minimal training and is very user-friendly – the vet just adds a blood sample on the disposable cartridge and reads the result on the 7” colour screen.
The Quickvet COAG test is the first of several test cartridges being rolled out by SMB, which will be used in conjunction with the QuickVet Analyzer. They will all use whole blood samples and provide novel in-clinic diagnostic capabilities within the areas of infectious diseases, parasites and parasite transmitted diseases, toxicology, hormones, oncology and cardiology.
For further information on the QuickVet Analyser and QuickVet COAG test cartridges please contact:
Mr Ole Kring CEO Scandinavian Micro Biodevices ApS Gammelgaardsvej 87C DK-3520 Farum Denmark http://www.quickvet.net/ Telephone: +45 203 378 58
Guidance for veterinary surgeons and veterinary nurses on client confidentiality and microchipping has been amended by the RCVS.
The amendments deal with situations when a client presents an animal registered in another person's name, and a new flow diagram has been added to provide additional practical advice for vets and VNs dealing with these types of situations.
Animals can be registered in a different name to that of the client for various reasons. For example, an animal may have been re-homed or sold, but the details on its microchip have not been updated; it could have been stolen; or, the owners may be involved in a civil dispute.
Veterinary surgeons in practice may be unsure what to do in these situations. The new guidance informs veterinary surgeons about their options and provides advice on client confidentiality and data protection issues.
The College advises that veterinary nurses employed by a veterinary surgeon or practice should discuss the issues with a senior veterinary surgeon in the practice before breaching client confidentiality.
The amendments apply to Chapter 14 of the supporting guidance to the RCVS Code of Professional Conduct. The supporting guidance and flow diagram are available at: www.rcvs.org.uk/confidentiality.
A new company supplying pet chews to the veterinary profession has launched this month.
The Soft Chew Company has been set up by Kevin Ingram, owner of the veterinary supplier J.A.K Marketing and Niall McFerran, who has in the past worked for a number of veterinary healthcare companies including Animalcare, Ceva and Alstoe.
Kevin said: "The healthcare supplement market in the UK is worth over £20 million and rising but most customers are asked to use products which were designed for use on humans. The aim of The Soft Chew Company is to provide those health benefits in the form of treats that the dogs and cats will readily accept."
The new company's product range will be branded: "Chewz" and marketed as palatable healthcare supplements in order that they will not be confused with pharmaceutical products.
The range will initially consist of:
The Chewz range can be obtained from all wholesalers or directly from J.A.K Marketing.
For further information contact; info@thesoftchewcompany.co.uk or 01347 293150
Researchers from the Waltham Centre for Pet Nutrition have published two studies which reveal, for the first time, the most common bacterial species associated with gum disease in cats.
Working with veterinary dentists and the Harvard affiliated Forsyth Institute, researchers used DNA sequencing technologies to identify 267 bacterial species present in feline dental plaque and build a database detailing the differences between bacterial populations in healthy cats and those in cats with gum disease.
Dr. Ian Davis, Oral Health Researcher at WALTHAM, part of Mars Petcare, said: "This knowledge is a first step in understanding the potential for improving oral health of cats through dietary interventions that target disease-associated bacteria."
The studies also revealed that the bacterial species in feline plaque were more similar to those observed in canine plaque than to those found in humans. This suggests that interventions targeted at bacteria which cause oral disease in humans are unlikely to be effective in cats, and there is more potential to learn from interventions that work well in dogs.
Dr. Davis added: "It’s important for pet owners to know that cats are just as susceptible to gum disease as dogs and understand the importance of maintaining a good oral hygiene routine; ideally including tooth brushing and dental treats or a specific dental diet".
The first study was published in Veterinary Microbiology in February 2015. The second was published on 25th November in PLOS ONE, and can be downloaded here: http://dx.plos.org/10.1371/journal.pone.0136986.
A similar scheme will also be run for Australian colleagues wanting to spend time in the UK.
The programme will allow the company's vets to enhance their role internationally and to explore other parts of the world whilst furthering their career.
The programme is open to vets with over one year's experience, who want to work overseas and then return to their current practice afterwards.
Secondments are also available for staff in support office roles.
Staff will be able to return to their existing roles for up to 12 months, and thereafter a similar role will be made available to them in their region.
Graeme Cramb, Managing Director for CVS Australia, said: “Our vision is to be the veterinary company that most people want to work for and we believe this UK-Australia secondment scheme represents an attractive option for colleagues.
“As the first vet company to offer a UK-Australia secondment scheme, we hope that it enables our colleagues to learn from colleagues in a new territory, further their career and to lead to some exciting cross-pollination of ideas.”
When colleagues express an interest, they will be contacted by CVS recruitment team member to discuss potential opportunities that they can apply for.
They must meet the criteria required to be able to obtain a visa to work in Australia.
Successful applicants will be offered a relocation package and continue to be paid their salary in the UK.
They may also be eligible for the cost of living allowance, paid in Australia.
https://www.careerswithcvs.co.uk/intranet/vacancy/uk-to-australia-secondment-program-4472/18753/description/
Dechra Veterinary Products, manufacturer and distributor of Equipalazone®, has launched a new information leaflet to support the Equine Passport scheme.
Since 2005, when equine passports became mandatory, 958,000 have been issued. The passport is a method of identification as well as a medical record and ensures that horses treated with veterinary medicines do not enter the human food chain.
“Many substances used in commonly prescribed equine medicines can only be given to horses not intended for human consumption,” says Giles Coley, Dechra’s managing director. “Under the passport scheme, owners must declare whether their horse is intended for human consumption.
The leaflet, which outlines the importance and benefits of the Equine Passport scheme, will be inserted into every box of Equipalazone Powder 100 sachets. It will also be made available for veterinary practices to hand out to their clients.
Practices wishing or order copies of the Equine Passport leaflet should contact Rachel Horton at Dechra on 01743 441 632.
The British Equine Veterinary Association (BEVA) welfare award 2008, sponsored by The Blue Cross, has been presented to the Retraining of Racehorses (RoR) organisation for their contributions to equine welfare in support of the re-training and re-homing of racehorses.
The award, which was introduced by BEVA in conjunction with The Blue Cross animal welfare charity eight years ago, is a formal recognition of significant contributions made by veterinary surgeons and others to equine welfare.
It was presented to Ron Huggins, trustee of the ROR and an owner and breeder of racehorses, at the 47th BEVA Annual Congress in Liverpool on Friday 12 September 2008, by Kerstin Alford, equine welfare director of The Blue Cross.
Kerstin said: "The financial support that RoR provides for charitable racehorse rehabilitation centres, together with their education programme to help owners and riders of former racehorses, make them very worthy recipients of this award."
Di Arbuthnot, director of operations said: "RoR are delighted to receive this prestigious award to recognise the work the charity does for former racehorses to provide them with a life after racing."
Retraining of Racehorses was established in 2000 by the British Horseracing Authority. Its aim is to raise funds from the British racing industry to provide and maintain facilities for the care, retraining and rehoming of former racehorses. Under the direction of the chairman of the trustees Peter Deal, the RoR has become recognised as a vital component of the racing industry.
The Blue Cross was founded in 1897 to care for working horses on the streets of London, and equine welfare still plays a vital role in its work today. The charity rehabilitates and rehomes over a hundred horses and ponies every year at its equine centres in Burford (Oxon) and Rolleston-on-Dove (Staffordshire). A third facility in Northiam (East Sussex) provides rest and retirement for Blue Cross equines.
Genitrix is encouraging practices to capitalise on the growing market opportunity for dental treatments by offering a free pack of its Dentagen Dental Wax and a special offer of six products for the price of five for the rest of its Dentagen dental range during March 2010.
The company is also urging practices to declare March 'Dental Care Month' and to use it as a platform to step up the education they offer to pet owners on this important welfare issue.
According to Genitrix, the Dentagen range uses a plant extract called RF2 which operates as an 'anti-biofilm' treatment, modifying the membrane of oral bacteria to prevent them from producing plaque even at low concentrations. Dentagen Wax is applied to dogs or cats at the end of dental procedures in practice, while the animal is still sedated. It forms a protective coating over the teeth, which lasts for several days.
Each pack of wax contains five syringes enabling practices to offer free wax applications to pets during Dental Care Month. Pet owners can then maintain the protective coating by giving their pet either Dentagen plaque prevention chews every other day or the Dentagen Aqua drinking water additive.
For dogs, the chews are supplied in two sizes with the larger size designed for dogs over 8 kg and a smaller size for dogs less than 8 kg. Dentagen Aqua is a drinking water additive containing RF2. The company says the palatable liquid, which is added to a pet's drinking water, has proved particularly effective in treating cats which don't respond well to tooth-brushing or dental chews.
Rob Watkins, Genitrix' marketing director said: "It's well known that dental disease affects 80% of pets over three years' old and, if left untreated, can go on to cause serious health problems.
"Data from veterinary practices also confirms that many of them are not achieving the revenue they could from offering dental treatments to their clients. We want them to get their teeth into this important revenue opportunity so we're calling on practices to make March 'Dental Care Month' and are offering them a special deal on Dentagen products to get them started.
"The efficacy of the Dentagen range in inhibiting plaque formation has been proven in clinical trials and it has proved popular with pet owners, increasing their compliance with preventative health regimes."
To order your free pack of Dentagen Wax and to take advantage of the special offer on the rest of the range, contact Genitrix on 01403 786345 or by email at mail@genitrix.co.uk